[Metastatic apocrine adenocarcinoma of the penis: cytostatic therapy].

Metastatic carcinoma of the genital apocrine sweat glands is a rare clinical entity. A cytostatic treatment with MTX and bleomycin was performed empirically but did not show any satisfactory efficacy. The conversion of the chemotherapeutic regime to a tyrosine kinase inhibitor (sunitinib) showed a morphologically visible and clinically proven success in terms of a significant slowing down of the previous rapid progression of the disease.